Clinical Trial Update: Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating efficacy, safety, and costs of methotrexate, adalimumab, or their combination in non-infectious non-anterior uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Hospital San Carlos, Madrid | Conditions: Uveitis | Phase 3 | Status: UNKNOWN